Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

A microRNA causes disruptions in energy metabolism

No. 07c2 | 10/02/2015 | by Koh

Elevated levels of glucocorticoid hormones in the blood cause disruptions in energy metabolism. Scientists from the German Cancer Research Center, Heidelberg University and Heidelberg University Hospitals have now discovered that the culprit that causes blood lipid levels to rise is a microRNA molecule present in liver cells. The researchers were also able to demonstrate that blocking this microRNA can normalize metabolic processes.

Ball-and-stick model of the cortisol molecule
© Jynto, Wikimedia Commons

Glucocorticoid hormones such as the widely recognized hormone cortisol regulate numerous important functions in the body, including energy metabolism. They oppose the effects mediated by insulin, cause blood glucose levels to rise, promote the build-up of excess fat in the liver, and raise blood lipid (fat) levels.

Glucocorticoid hormone levels that are either too high or too low can lead to serious disorders such as Addison's disease or Cushing's syndrome, and can also contribute to certain symptoms found in Metabolic Syndrome such as obesity and insulin resistance. These metabolic disorders can also arise as a side effect of long-term, high-dose treatment with corticosteroids (i.e., synthetic cortisol).

“Glucocorticoid hormones play an important role in the regulation of energy metabolism, but we haven't fully understood this role yet,” says Professor Dr. Stephan Herzig, a metabolism expert who leads a joint research department between the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg University and Heidelberg University Hospital. “We wanted to find out how the disruption of blood glucose and lipid levels actually occurs in metabolic disorders that are characterized by too high a level of glucocorticoid hormones. We are interested in the underlying molecular mechanisms.”

Within the past few years, scientists have found evidence that so-called “microRNAs” can have important functions in metabolism control. MicroRNAs, or miRNAs, are transcripts of very short segments of the genome that usually contain around 20 nucleotides (RNA building blocks). Unlike the RNA that normally plays a role in the production of proteins, scientists have gradually come to realize over the past two decades that miRNAs instead regulate a variety of processes in the cell.

Therefore, Herzig's team took a closer look at specific microRNAs in the liver cells of mice with dysfunctional energy metabolism.

The researchers compared liver cells from diabetic mice that exhibited high glucocorticoid hormone levels with cells from healthy animals. They found that the cells from the diabetic animals produced noticeably higher quantities of a microRNA called miRNA-379. When the researchers turned off miRNA-379 in the livers of diseased mice, the animals’ dramatically elevated blood lipid levels went back to normal.

In order to find out whether miRNA-379 also plays a role in how humans metabolize lipids, the scientists analyzed liver tissue samples from 70 different people. They found that leaner people exhibited lower miRNA-379 levels in their liver tissue than obese people did. Higher miRNA-379 concentrations likewise corresponded with higher lipid levels in the blood.

“We were able to demonstrate for the first time that glucocorticoid hormone-regulated miRNA-379 is a key control switch for disruptions in lipid and glucose metabolism,” says Herzig. “Thus, we have also discovered a possible way to counteract this disastrous process: In order to normalize energy metabolism, it may be possible to use an agent that turns off miRNA-379. Methods to turn off microRNAs based on so-called ‘antisense technology’ are already available. It may therefore be possible in the foreseeable future to develop such an agent for this purpose.”

Roldan M de Guia, Adam J Rose, Anke Sommerfeld, Oksana Seibert, Daniela Strzoda, Annika Zota, Yvonne Feuchter, Anja Krones-Herzig, Tjeerd Sijmonsma, Milen Kirilov, Carsten Sticht, Norbert Gretz, Geesje Dallinga-Thie, Sven Diederichs, Nora Klöting, Matthias Blüher, Mauricio Berriel Diaz and Stephan Herzig: MicroRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis. EMBO Journal 2014, DOI: 10.15252/embj.201490464

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS